Value Over Profit

Albert emphasizes that prioritizing patient outcomes and breakthroughs is essential for true value creation in the pharmaceutical industry. He asserts that focusing solely on profit can hinder progress and that regulatory standards ensure unbiased study conduct. Ultimately, he believes that when the primary goal is to help patients, financial success will naturally follow.